Back to Search Start Over

Low-Dose Cisplatin-Based Radiation Therapy for Refractory Recurrent Respiratory Papillomatosis.

Authors :
Takatsuki E
Kono T
Tomisato S
Ozawa H
Source :
The Laryngoscope [Laryngoscope] 2024 May; Vol. 134 (5), pp. 2335-2337. Date of Electronic Publication: 2023 Oct 09.
Publication Year :
2024

Abstract

Recurrent respiratory papilloma (RRP) often presents multiple lesions in the respiratory tract and sometimes becomes fatal because of severe airway obstruction. We report the case of a 69-year-old woman who had juvenile-onset RRP in the trachea that was refractory to surgical treatment, and complete remission was achieved by low-dose cisplatin combined with de-escalated radiotherapy without any side effects. This case report is the first to illustrate the data on low-dose cisplatin for refractory benign RRP, and our experience reinforces the opinion that low-dose cisplatin combined with de-escalated radiotherapy can be an effective and safe treatment alternative for uncontrollable and lethal RRP. Laryngoscope, 134:2335-2337, 2024.<br /> (© 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.)

Details

Language :
English
ISSN :
1531-4995
Volume :
134
Issue :
5
Database :
MEDLINE
Journal :
The Laryngoscope
Publication Type :
Report
Accession number :
37812337
Full Text :
https://doi.org/10.1002/lary.31096